Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.6 USD | -3.23% | -2.69% | +70.11% |
May. 30 | Transcript : Natera, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM | |
May. 23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
Chart calendar Natera, Inc.
Upcoming events on Natera, Inc.
Past events on Natera, Inc.
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 3586 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 10596 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # LBA507 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 6056 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 5034 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 518 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 569 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 9564 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 549 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 4028 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # TPS8659 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 4587 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No # 3609 |
2024-05-30 11:40 am | Leerink Partners Healthcare Crossroads Conference |
2024-05-17 | ACOG Clinical & Scientific Meeting |
2024-05-09 04:30 pm | Q1 2024 Earnings Call |
2024-05-09 04:05 pm | Q1 2024 Earnings Release |
2024-03-17 04:45 pm | Society of Gynecologic Oncology Meeting - Mike Shalamov |
2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number - #1274 |
2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number - #1243 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 302 297 1.84% | 391 385 1.5% | 625 621 0.64% | 820 819 0.12% | 1 083 1 054 2.72% | 1 432 |
EBITDA Million USD | Released Forecast Spread | -123 -128 3.69% | -208 -184 -13.03% | -457 -433 -5.42% | -524 -523 -0.18% | -422 -421 -0.32% | -281 |
EBIT Million USD | Released Forecast Spread | -131 -127 -2.87% | -216 -191 -13.13% | -468 -449 -4.27% | -541 -539 -0.32% | -446 -447 0.08% | -313 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -123 -132 7.15% | -230 -204 -12.44% | -471 -453 -4.06% | -547 -547 0.06% | -435 -440 1.27% | -304 |
Net income Million USD | Released Forecast Spread | -125 -131 4.96% | -230 -204 -12.64% | -472 -453 -4.15% | -548 -549 0.17% | -435 -440 1.18% | -304 |
EPS USD | Released Forecast Spread | -1,79 -1,90 5.99% | -2,84 -2,54 -11.94% | -5,21 -5,02 -3.81% | -5,57 -5,59 0.42% | -3,78 -3,85 1.9% | -2,51 |
Announcement Date | 26/02/20 | 25/02/21 | 24/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 194 177 9.92% | 198 194 2.34% | 211 207 1.93% | 217 216 0.81% | 242 227 6.3% | 261 242 8.23% | 268 259 3.55% | 311 287 8.28% | 368 333 10.51% | 342 | 356 | 372 | 414 | 407 |
EBITDA Million USD | Released Forecast Spread | -134 -147 8.76% | -138 -134 -3.67% | -114 -136 16.42% | -138 -135 -2.14% | -133 -121 -10.32% | -107 -112 4.14% | -104 -101 -2.62% | -77,6 -69,4 -11.83% | -67,3 -67,3 0.04% | -74,6 | -72,1 | -61,9 | -27,9 | -43,4 |
EBIT Million USD | Released Forecast Spread | -137 -140 2.03% | -143 -143 0.26% | -119 -139 14.06% | -142 -140 -1.03% | -138 -125 -10.69% | -112 -120 6.37% | -111 -109 -1.91% | -84,5 -84,4 -0.19% | -74,3 -83,2 10.63% | -85,8 | -79,9 | -73,4 | -51,8 | -52,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -138 -143 2.92% | -145 -145 -0.04% | -121 -142 14.56% | -142 -143 0.36% | -137 -129 -5.9% | -111 -123 9.45% | -109 -111 1.65% | -77,8 -83,3 6.52% | -67,2 -85,1 21.09% | -84,6 | -79,8 | -71,5 | -51,5 | -45,5 |
Net income Million USD | Released Forecast Spread | -139 -142 2.26% | -145 -145 0.11% | -121 -142 14.44% | -143 -144 1.13% | -137 -128 -6.67% | -111 -122 9.39% | -109 -110 0.89% | -78,0 -83,3 6.38% | -67,6 -85,3 20.72% | -84,8 | -79,9 | -71,7 | -51,5 | -45,6 |
EPS USD | Released Forecast Spread | -1,45 -1,49 2.67% | -1,50 -1,50 0.05% | -1,25 -1,45 13.86% | -1,37 -1,42 3.44% | -1,23 -1,16 -5.9% | -0,97 -1,08 10.53% | -0,95 -0,96 0.81% | -0,64 -0,71 9.44% | -0,56 -0,70 19.46% | -0,70 | -0,65 | -0,58 | -0,40 | -0,36 |
Announcement Date | 05/05/22 | 04/08/22 | 08/11/22 | 28/02/23 | 09/05/23 | 03/08/23 | 08/11/23 | 28/02/24 | 10/05/24 | - | - | - | - | - |
Past sector events for Natera, Inc.
2024-05-29 02:40 pm | HEALTHCARE GLOBAL ENTERPRISES LIMITED: Q4 2024 Earnings Release |
2024-05-26 04:30 pm | RYMAN HEALTHCARE LIMITED: Q4 2024 Earnings Release |
2024-05-22 04:15 pm | AUNA S.A.: Q1 2024 Earnings Release |
2024-05-22 06:15 am | CORVEL CORPORATION: Q4 2024 Earnings Release |
2024-05-22 05:33 am | MAX HEALTHCARE INSTITUTE LIMITED: Q4 2024 Earnings Release |
2024-05-22 01:05 am | LIFE HEALTHCARE GROUP HOLDINGS LIMITED: Q2 2024 Earnings Release |
2024-05-16 09:32 pm | PT FAMON AWAL BROS SEDAYA TBK: Q1 2024 Earnings Release |
2024-05-16 08:15 am | KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED: Q4 2024 Earnings Release |
2024-05-15 | RAMKHAMHAENG HOSPITAL: Q1 2024 Earnings Release |
2024-05-14 | DIAGNOSTICOS DA AMÉRICA S.A.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NTRA Stock
- Calendar Natera, Inc.